Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Stem Cell Reports|January 12, 2017
RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem CellsHarry O King, Tim Brend, Helen L Payne, et al.Anesthesiology and Pain Medicine|June 21, 2021
Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic PainJanell Tully, Jai Won Jung, Anjana Patel, et al.Methods (San Diego, Calif.)|October 4, 2015
The synthesis of recombinant membrane proteins in yeast for structural studiesSarah J Routledge, Lina Mikaliunaite, Anjana Patel, et al.Psychopharmacology Bulletin|August 1, 2020
Naldemedine for the Use of Management of Opioid Induced ConstipationIvan Urits, Anjana Patel, Hayley Cornwall Kiernan, et al.Pain and Therapy|February 29, 2020
Injection Techniques for Common Chronic Pain Conditions of the Foot: A Comprehensive ReviewIvan Urits, Daniel Smoots, Henry Franscioni, et al.Journal of Medicinal Chemistry|December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes MellitusChafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.Nature Communications|April 27, 2018
Structural basis for GPR40 allosteric agonism and incretin stimulationJoseph D Ho, Betty Chau, Logan Rodgers, et al.Science Translational Medicine|August 17, 2018
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in miceEuan S Polson, Verena B Kuchler, Christopher Abbosh, et al.Journal of Medicinal Chemistry|October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.Pageof 2